BioCentury | Feb 23, 2021
Distillery Therapeutics
Endocytic protein SH3GL1 as an autoimmune arthritis target
DISEASE CATEGORY: Autoimmune INDICATION: Arthritis; rheumatoid arthritis (RA) Inhibiting the endocytic protein SH3GL1 could treat autoimmune arthritis, including RA. CD4+ T cells from eight RA patients had higher mRNA levels of SH3GL1 than cells from...